🇷🇺🇺🇸 Путин провёл в четверг телефонный разговор с Трампом — сообщение об этом появилось на сайте Кремля

🇷🇺🇺🇸 On Thursday, Putin and Trump held telephone negotiation — message about this appeared on the Kremlin website

⚡️🇨🇳🇺🇸 China demanded from the United States to close the consulate general in Chengdu (Sichuan province). This is stated in a statement published on the website of Chinese Foreign Ministry

Now Chinese have put a camera in front of embassy gate and staged a live broadcast
https://youtu.be/jpPEpLz-8Cc

❗️At the same time, Consul General of China in Houston Cai Wei said Politico that he's not going to close office in Houston, refusing to comply with US State Department's demand to close office by Friday


⚡️🇨🇳🇺🇸 Китай потребовал от США закрыть генеральное консульство в городе Чэнду (провинция Сычуань). Об этом говорится в заявлении, опубликованном на сайте Министерства иностранных дел Китая

Сейчас китайцы поставили камеру напротив ворот посольства и устроили прямую трансляцию
https://youtu.be/jpPEpLz-8Cc

❗️В то же время генеральный консул Китая в Хьюстоне Цай Вэй заявил в интервью Politico, что не собирается закрывать офис в Хьюстоне, отказавшись подчиниться требования Госдепа закрыть офис к пятнице

🇨🇳🇲🇽 Chinese Foreign Minister Wang Yi said China is willing to provide its Latin American and Caribbean friends with a $ 1 billion loan to purchase a Chinese vaccine for COVID-19, the Mexican Foreign Ministry said Wednesday.

🧬The adenovirus vector-based vaccine Ad5-nCoV was developed in collaboration with the Chinese Academy of Military Medical Sciences. Permission to use it was obtained on June 25 for a period of one year. Ad5-nCoV is currently limited to military use


🇨🇳🇲🇽 Министр иностранных дел Китая Ван И заявил, что Китай готов выделить своим друзьям из Латинской Америки и Карибского бассейна кредит в размере $1 млрд. для закупки китайской вакцины от COVID-19, сообщило в среду мексиканское министерство иностранных дел.

🧬Вакцина Ad5-nCoV, основанная на аденовирусном векторе, была разработана совместно с Академией военно-медицинских наук Китая. Разрешение на ее использование было получено 25 июня сроком на один год. В настоящее время Ad5-nCoV ограничена военным использованием

🇬🇧🇸🇪🇨🇳 The main competitor of the Chinese vaccine in Latin America - AZD1222 (ChAdOx1-S) vaccine, developed by specialists from the University of Oxford in conjunction with the British-Swedish pharmaceutical company AstraZeneca, registered in the UK.

By accidental coincidence, a few hours after the generous offer of Chinese, several articles appeared in the media stating that "the vaccine created by the Oxford scientists has exceeded all expectations" and received the approval of FDA

🧬At the moment, these are 2 of 6 vaccines that have passed the third phase of trials (of these six vaccines, 4 are Chinese)

▪️It was previously reported that more than 600 people took part in the trials of the Chinese vaccine. The vaccine triggered an immune response.

▪️As for ChAdOx1 nCoV-19 vaccine, in previous trials, 70% of 1,077 volunteers had fever or headache. Apparently, this problem has been solved: the developers report that "the vaccine provides both antibody production and a T-cell response."

🦠 True, as scientists from Tsinghua University in Beijing recently found out, antibodies will not help: the more antibodies produced by Covid-19 patients, the worse the outcome – the patient dies due to strongest antibody response